Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.76 |
| ▸ | CD274 | Q9NZQ7 | 14/20 | 0.60 |
| ▸ | PDCD1 | Q15116 | 6/20 | 0.60 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.56 |
| ▸ | MAOA | P21397 | 3/20 | 0.56 |
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6167875 | 1.00 | SCN3A (0.76) | SCN3ACD274PDCD1SPHK1MAOA | |
| SCHEMBL6169037 | 0.91 | SCN3A (0.75) | SCN3ACD274PDCD1SPHK1MAOA | |
| SCHEMBL6169023 | 0.91 | SCN3A (0.75) | SCN3ACD274PDCD1SPHK1MAOA | |
| SCHEMBL6168141 | 0.91 | SCN3A (0.71) | SCN3ACD274PDCD1SPHK1MAOA | |
| SCHEMBL6168150 | 0.91 | SCN3A (0.71) | SCN3ACD274PDCD1SPHK1MAOA | |
| SCHEMBL31038644 | 0.80 | SCN3A (0.69) | SCN3ASPHK1MAOAMAOB | |
| SCHEMBL6171223 | 0.80 | SCN3A (0.64) | SCN3ACD274PDCD1SPHK1MAOA | |
| SCHEMBL6171218 | 0.80 | SCN3A (0.64) | SCN3ACD274PDCD1SPHK1MAOA | |
| SCHEMBL12961820 | 0.80 | SCN3A (0.64) | SCN3ACD274PDCD1SPHK1MAOA | |
| SCHEMBL6169438 | 0.79 | SCN3A (0.71) | SCN3ACD274PDCD1SPHK1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005040108-A1 | PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-05-06 | — | — | WO | claimed |
| EP-1524265-A1 | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors | Newron Pharmaceuticals S.p.A. (IT) | 2005-04-20 | — | — | EP | claimed |
| WO-2005040108-A1 | PROLINAMIDE DERIVATIVES AS SODIUM AND/OR CALCIUM CHANNEL BLOCKERS OR SELECTIVE MAO-B INHIBITORS | NEWRON PHARMACEUTICALS S.P.A. (IT) | 2005-05-06 | — | — | WO | disclosed |
| EP-1524265-A1 | Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors | Newron Pharmaceuticals S.p.A. (IT) | 2005-04-20 | — | — | EP | disclosed |